The costs for genetic blood count tests (e.g., analyzing variants affecting hemoglobin, iron metabolism, or coagulation) vary widely depending on provider, scope, and country. In the direct-to-consumer (DTC) space like MyBody-X, prices typically range from €50 to €200 for a basic panel that may include some blood-related SNPs. Specialized hematology genetic tests (e.g., for hemochromatosis, thalassemia) in clinical diagnostics can cost €200–€500, but are often covered by insurance if medically indicated. Importantly, the provided context contains no specific pricing data. The evidence for such tests is often mechanistic or based on GWAS associations; a direct benefit for health management without medical supervision is unproven. Moreover, many blood count genetic markers are population-dependent (e.g., rs174575 for omega-3/6 metabolism) and have small effect sizes. Consumers should be wary of expensive add-on analyses that claim to optimize personal blood counts. A conventional blood test from a doctor is inexpensive (approx. €5–€20) and clinically validated. In summary, the costs of genetic blood tests are often not justified by added value unless there is a specific family history or clinical indication.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-5f58778025cfcf1a5027ae8a